speb/financial-data huggingface dataset:
BMA cash_flow (annual, 2022-12-31) — Repayment Of Debt: -66121926000.00
BMA balance_sheet (annual, 2022-12-31) — Retained Earnings: -249980896000.00
BMA income_statement (annual, 2022-12-31) — Salaries And Wages: 539884432000.00
BMA income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 16104975000.00
BMA income_statement (annual, 2022-12-31) — Selling General And Administration: 764439596000.00
BMA balance_sheet (annual, 2022-12-31) — Share Issued: 647052567.00
BMA income_statement (annual, 2022-12-31) — Special Income Charges: -1555496718000.00
BMA balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1594856139000.00
BMA balance_sheet (annual, 2022-12-31) — Tangible Book Value: 1540547385000.00
BMA income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -483401738797.00
BMA income_statement (annual, 2022-12-31) — Tax Provision: 124572053000.00
BMA income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.31
BMA cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -18243607000.00
BMA balance_sheet (annual, 2022-12-31) — Total Assets: 6508793934000.00
BMA balance_sheet (annual, 2022-12-31) — Total Capitalization: 1827930415000.00
BMA balance_sheet (annual, 2022-12-31) — Total Debt: 239194239000.00
BMA balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1595119874000.00
BMA balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 4913674060000.00
BMA balance_sheet (annual, 2022-12-31) — Total Tax Payable: 107203884000.00
BMA income_statement (annual, 2022-12-31) — Total Unusual Items: -1554346427000.00
BMA income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -1554346427000.00
BMA income_statement (annual, 2023-12-31) — +Total Revenue: 8080277478000.00
BMA balance_sheet (annual, 2023-12-31) — Accounts Receivable: 631058308000.00
BMA balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -440301177000.00
BMA balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 12429781000.00
BMA cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 30150454000.00
BMA cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 30150454000.00
BMA balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 4331492508000.00
BMA income_statement (annual, 2023-12-31) — Basic Average Shares: 63941300.00
BMA income_statement (annual, 2023-12-31) — Basic EPS: 9185.05
BMA cash_flow (annual, 2023-12-31) — Beginning Cash Position: 6689916820000.00
BMA cash_flow (annual, 2023-12-31) — Capital Expenditure: -163494821000.00
BMA balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 20445368000.00
BMA balance_sheet (annual, 2023-12-31) — Capital Stock: 639413000.00
BMA balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 2694676614000.00
BMA balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 4101493032000.00
BMA cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -514741000.00
BMA balance_sheet (annual, 2023-12-31) — Cash Financial: 865299956000.00
BMA cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -163055000.00
BMA cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 232961671000.00
BMA cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -244151798000.00
BMA cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 47294316000.00
BMA cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -237378948000.00
BMA cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -5740367484000.00
BMA cash_flow (annual, 2023-12-31) — Change In Working Capital: -5550170282000.00
BMA cash_flow (annual, 2023-12-31) — Changes In Cash: -11353182000.00
BMA balance_sheet (annual, 2023-12-31) — Common Stock: 639413000.00
BMA cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -514741000.00
BMA balance_sheet (annual, 2023-12-31) — Common Stock Equity: 4438608347000.00
BMA balance_sheet (annual, 2023-12-31) — Construction In Progress: 18611532000.00
BMA balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 37923585000.00
BMA cash_flow (annual, 2023-12-31) — Depreciation: 27948312000.00
BMA cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 166432836000.00
BMA income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 166432836000.00
BMA cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 166432836000.00
BMA income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 166432836000.00
BMA income_statement (annual, 2023-12-31) — Depreciation Income Statement: 126517980000.00
BMA balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 6179869000.00
BMA income_statement (annual, 2023-12-31) — Diluted Average Shares: 63941300.00
BMA income_statement (annual, 2023-12-31) — Diluted EPS: 9185.05
BMA income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 1667326227000.00
BMA balance_sheet (annual, 2023-12-31) — Dividends Payable: 174519000.00
BMA cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 2604739482000.00
BMA balance_sheet (annual, 2023-12-31) — Employee Benefits: 80713844000.00
BMA cash_flow (annual, 2023-12-31) — End Cash Position: 3966049242000.00
BMA cash_flow (annual, 2023-12-31) — Financing Cash Flow: -163055000.00
BMA cash_flow (annual, 2023-12-31) — Free Cash Flow: -407646619000.00
BMA income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 2791027158000.00
BMA balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 2743210637000.00
BMA income_statement (annual, 2023-12-31) — General And Administrative Expense: 1199745471000.00
BMA balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 163694286000.00
BMA balance_sheet (annual, 2023-12-31) — Gross PPE: 1217254335000.00
BMA cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 4487694972000.00
BMA balance_sheet (annual, 2023-12-31) — Income Tax Payable: 637595968000.00
BMA income_statement (annual, 2023-12-31) — Insurance And Claims: 38631895000.00
BMA income_statement (annual, 2023-12-31) — Interest Expense: 4671590790000.00
BMA income_statement (annual, 2023-12-31) — Interest Income: 7038288245000.00
BMA balance_sheet (annual, 2023-12-31) — Invested Capital: 5281553506000.00
BMA cash_flow (annual, 2023-12-31) — Investing Cash Flow: 232961671000.00
BMA balance_sheet (annual, 2023-12-31) — Investments And Advances: 4970355400000.00
BMA cash_flow (annual, 2023-12-31) — Issuance Of Debt: 84441835000.00
BMA balance_sheet (annual, 2023-12-31) — Leases: 16684870000.00
BMA balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 20445368000.00
BMA balance_sheet (annual, 2023-12-31) — Long Term Debt: 842945159000.00
BMA balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 863390527000.00
BMA cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 84441835000.00
BMA cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -72816193000.00
BMA balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 3669558000.00
BMA balance_sheet (annual, 2023-12-31) — Long Term Provisions: 19191370000.00
BMA balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 418977457000.00
BMA balance_sheet (annual, 2023-12-31) — Minority Interest: 1014532000.00
BMA income_statement (annual, 2023-12-31) — Minority Interests: -1004753000.00
BMA cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -62897745000.00
BMA cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -1488724579000.00
BMA income_statement (annual, 2023-12-31) — Net Income: 1667326227000.00
BMA income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 1667326227000.00
BMA income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 1668330980000.00
BMA income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 1667326227000.00
BMA income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 1667326227000.00
BMA cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 2477083018000.00
BMA income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 1668330980000.00
BMA income_statement (annual, 2023-12-31) — Net Interest Income: 2366697455000.00
BMA cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 11625642000.00
BMA cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 11625642000.00
BMA cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -11273956000.00
BMA cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 459354237000.00
BMA balance_sheet (annual, 2023-12-31) — Net PPE: 776953158000.00
BMA cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -163494821000.00
BMA balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 4274914061000.00
BMA balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 98899291000.00
BMA balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 98899291000.00
BMA balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3458899000.00
BMA income_statement (annual, 2023-12-31) — Normalized Income: 4196524334278.00
BMA income_statement (annual, 2023-12-31) — Occupancy And Equipment: 46692100000.00
BMA cash_flow (annual, 2023-12-31) — Operating Cash Flow: -244151798000.00
BMA cash_flow (annual, 2023-12-31) — Operating Gains Losses: -1488724579000.00
BMA income_statement (annual, 2023-12-31) — Operating Revenue: 8080277478000.00
BMA balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 639413408.00
BMA cash_flow (annual, 2023-12-31) — Other Cash Adjustment Outside Changein Cash: -5317253878000.00
BMA balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 2743210637000.00
BMA balance_sheet (annual, 2023-12-31) — Other Equity Interest: 1250693939000.00
BMA income_statement (annual, 2023-12-31) — Other Gand A: 284800901000.00
BMA balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 163694286000.00
BMA cash_flow (annual, 2023-12-31) — Other Non Cash Items: 4095583175000.00
BMA income_statement (annual, 2023-12-31) — Other Non Interest Expense: 730522172000.00
BMA income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -2850305910000.00
BMA balance_sheet (annual, 2023-12-31) — Other Payable: 765967232000.00
BMA balance_sheet (annual, 2023-12-31) — Other Properties: 762980476000.00
BMA balance_sheet (annual, 2023-12-31) — Other Receivables: 231222657000.00
BMA balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 635193334000.00
BMA income_statement (annual, 2023-12-31) — Other Special Charges: 3753500108000.00
BMA balance_sheet (annual, 2023-12-31) — Payables: 1403737719000.00
BMA balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 1441661304000.00
BMA balance_sheet (annual, 2023-12-31) — Prepaid Assets: 51726136000.00
BMA income_statement (annual, 2023-12-31) — Pretax Income: 2477083018000.00
BMA cash_flow (annual, 2023-12-31) — Purchase Of Business: -62897745000.00
BMA cash_flow (annual, 2023-12-31) — Purchase Of PPE: -163494821000.00
BMA balance_sheet (annual, 2023-12-31) — Receivables: 862280965000.00
BMA income_statement (annual, 2023-12-31) — Reconciled Depreciation: 166432836000.00
BMA income_statement (annual, 2023-12-31) — Rent And Landing Fees: 1349001000.00
BMA income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 1349001000.00
BMA cash_flow (annual, 2023-12-31) — Repayment Of Debt: -72816193000.00
BMA balance_sheet (annual, 2023-12-31) — Retained Earnings: 431634577000.00
BMA income_statement (annual, 2023-12-31) — Salaries And Wages: 874963674000.00
BMA income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 51379769000.00
BMA income_statement (annual, 2023-12-31) — Selling General And Administration: 1251125240000.00
BMA balance_sheet (annual, 2023-12-31) — Share Issued: 639413408.00
BMA income_statement (annual, 2023-12-31) — Special Income Charges: -3753500108000.00
BMA balance_sheet (annual, 2023-12-31) — Stockholders Equity: 4438608347000.00
BMA balance_sheet (annual, 2023-12-31) — Tangible Book Value: 4274914061000.00
BMA income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -1223321339722.00
BMA income_statement (annual, 2023-12-31) — Tax Provision: 808752038000.00
BMA income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.33
BMA cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -76040493000.00
BMA balance_sheet (annual, 2023-12-31) — Total Assets: 14629820194000.00
BMA balance_sheet (annual, 2023-12-31) — Total Capitalization: 5281553506000.00
BMA balance_sheet (annual, 2023-12-31) — Total Debt: 863390527000.00
BMA balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 4439622879000.00
BMA balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 10190197315000.00
BMA balance_sheet (annual, 2023-12-31) — Total Tax Payable: 637595968000.00
BMA income_statement (annual, 2023-12-31) — Total Unusual Items: -3752519447000.00
BMA income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -3752519447000.00
BMA income_statement (quarterly, 2024-09-30) — +Total Revenue: 1072090925000.00
BMA balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 99062188000.00
BMA balance_sheet (quarterly, 2024-09-30) — Accumulated Depreciation: -320259006000.00
BMA balance_sheet (quarterly, 2024-09-30) — Additional Paid In Capital: 12429781000.00
BMA balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 3677556821000.00
BMA income_statement (quarterly, 2024-09-30) — Basic Average Shares: 63941300.00
BMA income_statement (quarterly, 2024-09-30) — Basic EPS: 1872.53
BMA cash_flow (quarterly, 2024-09-30) — Beginning Cash Position: 2343306804000.00
BMA cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -44267649000.00
BMA balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 13900236000.00
BMA balance_sheet (quarterly, 2024-09-30) — Capital Stock: 639413000.00
BMA balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 3531975204000.00
BMA balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Federal Funds Sold: 3531976161000.00
BMA cash_flow (quarterly, 2024-09-30) — Cash Dividends Paid: -211927177000.00
BMA balance_sheet (quarterly, 2024-09-30) — Cash Financial: 1167672727000.00
BMA cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Financing Activities: -217177622000.00
BMA cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Investing Activities: -44312111000.00
BMA cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Operating Activities: 2459092370000.00
BMA cash_flow (quarterly, 2024-09-30) — Change In Other Current Assets: -780722279000.00
BMA cash_flow (quarterly, 2024-09-30) — Change In Other Current Liabilities: 1042132564000.00
BMA cash_flow (quarterly, 2024-09-30) — Change In Other Working Capital: 2858189950000.00
BMA cash_flow (quarterly, 2024-09-30) — Change In Working Capital: 2292606658000.00
BMA cash_flow (quarterly, 2024-09-30) — Changes In Cash: 2197602637000.00
BMA balance_sheet (quarterly, 2024-09-30) — Common Stock: 639413000.00
BMA cash_flow (quarterly, 2024-09-30) — Common Stock Dividend Paid: -211927177000.00
BMA balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 3641918324000.00
BMA balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 29285696000.00
BMA cash_flow (quarterly, 2024-09-30) — Depreciation Amortization Depletion: 44966812000.00
BMA income_statement (quarterly, 2024-09-30) — Depreciation Amortization Depletion Income Statement: 40324377000.00
BMA cash_flow (quarterly, 2024-09-30) — Depreciation And Amortization: 44966812000.00
BMA income_statement (quarterly, 2024-09-30) — Depreciation And Amortization In Income Statement: 40324377000.00
BMA income_statement (quarterly, 2024-09-30) — Depreciation Income Statement: 30605000000.00
BMA balance_sheet (quarterly, 2024-09-30) — Derivative Product Liabilities: 1437814000.00
BMA income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 63941300.00
BMA income_statement (quarterly, 2024-09-30) — Diluted EPS: 1872.53
BMA income_statement (quarterly, 2024-09-30) — Diluted NI Availto Com Stockholders: 119731992000.00
BMA balance_sheet (quarterly, 2024-09-30) — Dividends Payable: 1229000.00
BMA cash_flow (quarterly, 2024-09-30) — Effect Of Exchange Rate Changes: 98321578000.00
BMA balance_sheet (quarterly, 2024-09-30) — Employee Benefits: 4461848000.00
BMA cash_flow (quarterly, 2024-09-30) — End Cash Position: 4629710544000.00
BMA cash_flow (quarterly, 2024-09-30) — Financing Cash Flow: -217177622000.00
BMA cash_flow (quarterly, 2024-09-30) — Free Cash Flow: 2414824721000.00
BMA income_statement (quarterly, 2024-09-30) — Gain On Sale Of Security: 136481658000.00
BMA income_statement (quarterly, 2024-09-30) — General And Administrative Expense: 308532369000.00
BMA balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 140642680000.00
BMA balance_sheet (quarterly, 2024-09-30) — Gross PPE: 1051211998000.00
BMA balance_sheet (quarterly, 2024-09-30) — Income Tax Payable: 126849718000.00
BMA income_statement (quarterly, 2024-09-30) — Insurance And Claims: 7497765000.00
BMA income_statement (quarterly, 2024-09-30) — Interest Expense: 393373145000.00
BMA income_statement (quarterly, 2024-09-30) — Interest Income: 1136192090000.00
BMA balance_sheet (quarterly, 2024-09-30) — Invested Capital: 4106661517000.00
BMA cash_flow (quarterly, 2024-09-30) — Investing Cash Flow: -44312111000.00
BMA balance_sheet (quarterly, 2024-09-30) — Investments And Advances: 4058701187000.00
BMA balance_sheet (quarterly, 2024-09-30) — Leases: 63885651000.00
BMA balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 13900236000.00
BMA balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 464743193000.00
BMA balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 478643429000.00
BMA cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: -1574974000.00
BMA balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 4662473000.00
BMA balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 16624007000.00
BMA balance_sheet (quarterly, 2024-09-30) — Machinery Furniture Equipment: 256172554000.00
BMA balance_sheet (quarterly, 2024-09-30) — Minority Interest: 841281000.00
BMA income_statement (quarterly, 2024-09-30) — Minority Interests: -590299000.00
BMA cash_flow (quarterly, 2024-09-30) — Net Foreign Currency Exchange Gain Loss: -53687037000.00
BMA income_statement (quarterly, 2024-09-30) — Net Income: 119731992000.00
BMA income_statement (quarterly, 2024-09-30) — Net Income Common Stockholders: 119731992000.00
BMA income_statement (quarterly, 2024-09-30) — Net Income Continuous Operations: 120322291000.00
BMA income_statement (quarterly, 2024-09-30) — Net Income From Continuing And Discontinued Operation: 119731992000.00
BMA income_statement (quarterly, 2024-09-30) — Net Income From Continuing Operation Net Minority Interest: 119731992000.00
BMA cash_flow (quarterly, 2024-09-30) — Net Income From Continuing Operations: 165278112000.00
BMA income_statement (quarterly, 2024-09-30) — Net Income Including Noncontrolling Interests: 120322291000.00
BMA income_statement (quarterly, 2024-09-30) — Net Interest Income: 742818945000.00
BMA cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: -1574974000.00
BMA cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: -1574974000.00
BMA cash_flow (quarterly, 2024-09-30) — Net Other Financing Charges: -3675471000.00
BMA cash_flow (quarterly, 2024-09-30) — Net Other Investing Changes: -44462000.00
BMA balance_sheet (quarterly, 2024-09-30) — Net PPE: 730952992000.00
BMA cash_flow (quarterly, 2024-09-30) — Net PPE Purchase And Sale: -44267649000.00
BMA balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 3501275644000.00
BMA balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Liabilities: 47243130000.00
BMA balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 47243130000.00
BMA balance_sheet (quarterly, 2024-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 4461848000.00
BMA income_statement (quarterly, 2024-09-30) — Normalized Income: 402152963435.43
BMA cash_flow (quarterly, 2024-09-30) — Operating Cash Flow: 2459092370000.00
BMA cash_flow (quarterly, 2024-09-30) — Operating Gains Losses: -53687037000.00
BMA income_statement (quarterly, 2024-09-30) — Operating Revenue: 1072090925000.00
BMA balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 628177738.00
BMA cash_flow (quarterly, 2024-09-30) — Other Cash Adjustment Outside Changein Cash: -216622110000.00
BMA balance_sheet (quarterly, 2024-09-30) — Other Equity Adjustments: 2275709218000.00
BMA balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 1156779807000.00
BMA income_statement (quarterly, 2024-09-30) — Other Gand A: 82083560000.00
BMA balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 140642680000.00
BMA cash_flow (quarterly, 2024-09-30) — Other Non Cash Items: 40451674000.00
BMA income_statement (quarterly, 2024-09-30) — Other Non Interest Expense: 153468849000.00
BMA income_statement (quarterly, 2024-09-30) — Other Non Operating Income Expenses: -374052749000.00
BMA balance_sheet (quarterly, 2024-09-30) — Other Payable: 1614964773000.00
BMA balance_sheet (quarterly, 2024-09-30) — Other Properties: 701868097000.00
BMA balance_sheet (quarterly, 2024-09-30) — Other Receivables: 943593912000.00
BMA balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 376481893000.00
BMA income_statement (quarterly, 2024-09-30) — Other Special Charges: 374155525000.00
BMA balance_sheet (quarterly, 2024-09-30) — Payables: 1741815720000.00
BMA balance_sheet (quarterly, 2024-09-30) — Payables And Accrued Expenses: 1741815720000.00
BMA balance_sheet (quarterly, 2024-09-30) — Prepaid Assets: 25294430000.00
BMA income_statement (quarterly, 2024-09-30) — Pretax Income: 159221773000.00
BMA income_statement (quarterly, 2024-09-30) — Professional Expense And Contract Services Expense: 12563000000.00
BMA cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: -44267649000.00
BMA balance_sheet (quarterly, 2024-09-30) — Receivables: 1042656100000.00
BMA income_statement (quarterly, 2024-09-30) — Reconciled Depreciation: 44966812000.00
BMA income_statement (quarterly, 2024-09-30) — Rent And Landing Fees: 350978000.00
BMA income_statement (quarterly, 2024-09-30) — Rent Expense Supplemental: 350978000.00
BMA cash_flow (quarterly, 2024-09-30) — Repayment Of Debt: -1574974000.00
BMA balance_sheet (quarterly, 2024-09-30) — Retained Earnings: 196360105000.00
BMA income_statement (quarterly, 2024-09-30) — Salaries And Wages: 218600066000.00
BMA income_statement (quarterly, 2024-09-30) — Selling And Marketing Expense: 7461425000.00
BMA income_statement (quarterly, 2024-09-30) — Selling General And Administration: 315993794000.00
BMA balance_sheet (quarterly, 2024-09-30) — Share Issued: 628177738.00
BMA income_statement (quarterly, 2024-09-30) — Special Income Charges: -374155525000.00
BMA balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 3641918324000.00
BMA balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 3501275644000.00
BMA income_statement (quarterly, 2024-09-30) — Tax Effect Of Unusual Items: -91305022564.57
BMA income_statement (quarterly, 2024-09-30) — Tax Provision: 38899482000.00
BMA income_statement (quarterly, 2024-09-30) — Tax Rate For Calcs: 0.24
BMA cash_flow (quarterly, 2024-09-30) — Taxes Refund Paid: -64014676000.00
BMA balance_sheet (quarterly, 2024-09-30) — Total Assets: 14237764056000.00
BMA balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 4106661517000.00
BMA balance_sheet (quarterly, 2024-09-30) — Total Debt: 478643429000.00
BMA balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 3642759605000.00
BMA balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 10595004451000.00
BMA balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 126849718000.00
BMA income_statement (quarterly, 2024-09-30) — Total Unusual Items: -373725994000.00
BMA income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: -373725994000.00
BMA income_statement (annual, 2024-12-31) — +Total Revenue: 5949817365000.00
BMA income_statement (quarterly, 2024-12-31) — +Total Revenue: 1086773191000.00
BMA balance_sheet (annual, 2024-12-31) — Accounts Receivable: 668674205000.00
BMA balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 668674205000.00
BMA balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -371753420000.00
BMA balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -371753420000.00
BMA balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 12429781000.00
BMA balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 12429781000.00
BMA cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 73563653000.00
BMA cash_flow (quarterly, 2024-12-31) — Amortization Cash Flow: 23612261000.00
BMA cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 73563653000.00
BMA cash_flow (quarterly, 2024-12-31) — Amortization Of Intangibles: 23612261000.00
BMA balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 4901004600000.00
BMA balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 4901004600000.00
BMA income_statement (annual, 2024-12-31) — Basic Average Shares: 63941300.00
BMA income_statement (annual, 2024-12-31) — Basic EPS: 5069.39
BMA cash_flow (annual, 2024-12-31) — Beginning Cash Position: 3966049242000.00
BMA cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 3513810249000.00
BMA cash_flow (annual, 2024-12-31) — Capital Expenditure: -163799643000.00
BMA cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -38164503000.00
BMA balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 18401874000.00
BMA balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 18401874000.00
BMA balance_sheet (annual, 2024-12-31) — Capital Stock: 639413000.00
BMA balance_sheet (quarterly, 2024-12-31) — Capital Stock: 639413000.00
BMA balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 3651940330000.00
BMA balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 3651940330000.00
BMA balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 3682231644000.00
BMA balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 3682231644000.00
BMA cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -614254882000.00
BMA cash_flow (quarterly, 2024-12-31) — Cash Dividends Paid: -34699812000.00
BMA balance_sheet (annual, 2024-12-31) — Cash Financial: 547320305000.00
BMA balance_sheet (quarterly, 2024-12-31) — Cash Financial: 547320305000.00
BMA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -778804437000.00
BMA cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: -110668150000.00
BMA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -175867288000.00
BMA cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -46738854000.00
BMA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 2633788066000.00
BMA cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: -507537281000.00
BMA cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -123451664000.00
BMA cash_flow (quarterly, 2024-12-31) — Change In Other Current Assets: 461667231000.00
BMA cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 157243062000.00
BMA cash_flow (quarterly, 2024-12-31) — Change In Other Current Liabilities: -653666676000.00
BMA cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 2031085396000.00
BMA cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: 128901059000.00
BMA cash_flow (annual, 2024-12-31) — Change In Working Capital: 1257732334000.00
BMA cash_flow (quarterly, 2024-12-31) — Change In Working Capital: -944385720000.00
BMA cash_flow (annual, 2024-12-31) — Changes In Cash: 1679116341000.00
BMA cash_flow (quarterly, 2024-12-31) — Changes In Cash: -664944285000.00
BMA balance_sheet (annual, 2024-12-31) — Common Stock: 639413000.00
BMA balance_sheet (quarterly, 2024-12-31) — Common Stock: 639413000.00
BMA cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -614254882000.00
BMA cash_flow (quarterly, 2024-12-31) — Common Stock Dividend Paid: -34699812000.00
BMA balance_sheet (annual, 2024-12-31) — Common Stock Equity: 5326518604000.00
BMA balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 5326518604000.00
BMA balance_sheet (annual, 2024-12-31) — Construction In Progress: 42616066000.00
BMA balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 42616066000.00
BMA balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 35024369000.00
BMA balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 35024369000.00
BMA balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 6369176000.00
BMA balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 6369176000.00
BMA balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 6369176000.00
BMA balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 6369176000.00
BMA balance_sheet (annual, 2024-12-31) — Current Provisions: 11744244000.00
BMA balance_sheet (quarterly, 2024-12-31) — Current Provisions: 11744244000.00
BMA cash_flow (annual, 2024-12-31) — Depreciation: 64576847000.00
BMA cash_flow (quarterly, 2024-12-31) — Depreciation: 21363126000.00
BMA cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 181722120000.00
BMA cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 44975387000.00
BMA income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 181722120000.00
BMA income_statement (quarterly, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 44975387000.00
BMA cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 181722120000.00
BMA cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 44975387000.00
BMA income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 181722120000.00
BMA income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 44975387000.00
BMA income_statement (annual, 2024-12-31) — Depreciation Income Statement: 138140500000.00
BMA balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 1738552000.00
BMA balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 1738552000.00
BMA income_statement (annual, 2024-12-31) — Diluted Average Shares: 63941300.00
BMA income_statement (annual, 2024-12-31) — Diluted EPS: 5069.38
BMA income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 428193992000.00
BMA income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 130522149000.00
BMA balance_sheet (annual, 2024-12-31) — Dividends Payable: 1616000.00
BMA balance_sheet (quarterly, 2024-12-31) — Dividends Payable: 1616000.00
BMA cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 481368055000.00
BMA cash_flow (quarterly, 2024-12-31) — Effect Of Exchange Rate Changes: 161720666000.00
BMA balance_sheet (annual, 2024-12-31) — Employee Benefits: 145410542000.00
BMA balance_sheet (quarterly, 2024-12-31) — Employee Benefits: 145410542000.00
BMA cash_flow (annual, 2024-12-31) — End Cash Position: 3766926716000.00
BMA cash_flow (quarterly, 2024-12-31) — End Cash Position: 2863521255000.00
BMA cash_flow (annual, 2024-12-31) — Financing Cash Flow: -778804437000.00
BMA cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: -110668150000.00
BMA cash_flow (annual, 2024-12-31) — Free Cash Flow: 2469988423000.00
BMA cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -545701784000.00
BMA income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 2923692448000.00
BMA income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 290038914000.00
BMA balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 4350258266000.00
BMA balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 4350258266000.00
BMA income_statement (annual, 2024-12-31) — General And Administrative Expense: 1316672076000.00
BMA income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 301360295000.00
BMA balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 194002732000.00
BMA balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 194002732000.00
BMA balance_sheet (annual, 2024-12-31) — Gross PPE: 1408743113000.00
BMA balance_sheet (quarterly, 2024-12-31) — Gross PPE: 1408743113000.00
BMA cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 2361606708000.00
BMA balance_sheet (annual, 2024-12-31) — Income Tax Payable: 216363353000.00
BMA balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 216363353000.00
BMA income_statement (annual, 2024-12-31) — Insurance And Claims: 39147577000.00
BMA income_statement (quarterly, 2024-12-31) — Insurance And Claims: 8183667000.00
BMA income_statement (annual, 2024-12-31) — Interest Expense: 2555500489000.00
BMA income_statement (quarterly, 2024-12-31) — Interest Expense: 412929706000.00
BMA income_statement (annual, 2024-12-31) — Interest Income: 4671870431000.00
BMA income_statement (quarterly, 2024-12-31) — Interest Income: 1028208411000.00
BMA balance_sheet (annual, 2024-12-31) — Invested Capital: 5895421225000.00
BMA balance_sheet (quarterly, 2024-12-31) — Invested Capital: 5895421225000.00
BMA cash_flow (annual, 2024-12-31) — Investing Cash Flow: -175867288000.00
BMA cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -46738854000.00
BMA balance_sheet (annual, 2024-12-31) — Investments And Advances: 5484167564000.00
BMA balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 5484167564000.00
BMA balance_sheet (annual, 2024-12-31) — Leases: 91847397000.00
BMA balance_sheet (quarterly, 2024-12-31) — Leases: 91847397000.00
BMA balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 18401874000.00
BMA balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 18401874000.00
BMA balance_sheet (annual, 2024-12-31) — Long Term Debt: 568902621000.00
BMA balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 568902621000.00
BMA balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 587304495000.00
BMA balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 587304495000.00
BMA cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -153573471000.00
BMA cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -73644755000.00
BMA balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 6053636000.00
BMA balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 6053636000.00
BMA balance_sheet (annual, 2024-12-31) — Long Term Provisions: 22511020000.00
BMA balance_sheet (quarterly, 2024-12-31) — Long Term Provisions: 22511020000.00
BMA balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 300816392000.00
BMA balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 300816392000.00
BMA balance_sheet (annual, 2024-12-31) — Minority Interest: 2143609000.00
BMA balance_sheet (quarterly, 2024-12-31) — Minority Interest: 2143609000.00
BMA income_statement (annual, 2024-12-31) — Minority Interests: -1301170000.00
BMA income_statement (quarterly, 2024-12-31) — Minority Interests: -260651000.00
BMA cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -11216178000.00
BMA cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -303462160000.00
BMA cash_flow (quarterly, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -124397750000.00
BMA income_statement (annual, 2024-12-31) — Net Income: 428193992000.00
BMA income_statement (quarterly, 2024-12-31) — Net Income: 130522149000.00
BMA income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 428193992000.00
BMA income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 130522149000.00
BMA income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 429495162000.00
BMA income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 130782800000.00
BMA income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 428193992000.00
BMA income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 130522149000.00
BMA income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 428193992000.00
BMA income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 130522149000.00
BMA cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 473594762000.00
BMA cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: 168220661000.00
BMA income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 429495162000.00
BMA income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 130782800000.00
BMA income_statement (annual, 2024-12-31) — Net Interest Income: 2116369942000.00
BMA income_statement (quarterly, 2024-12-31) — Net Interest Income: 615278705000.00
BMA cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -153573471000.00
BMA cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: -73644755000.00
BMA cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -153573471000.00
BMA cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -73644755000.00
BMA cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -10976084000.00
BMA cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -2323583000.00
BMA cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -851467000.00
BMA cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: -48100000.00
BMA balance_sheet (annual, 2024-12-31) — Net PPE: 1036989693000.00
BMA balance_sheet (quarterly, 2024-12-31) — Net PPE: 1036989693000.00
BMA cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -163799643000.00
BMA cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -38164503000.00
BMA balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 5132515872000.00
BMA balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 5132515872000.00
BMA balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 105429920000.00
BMA balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 105429920000.00
BMA balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 105429920000.00
BMA balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 105429920000.00
BMA balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 10328061000.00
BMA balance_sheet (quarterly, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 10328061000.00
BMA income_statement (annual, 2024-12-31) — Normalized Income: 3255393521868.75
BMA income_statement (quarterly, 2024-12-31) — Normalized Income: 138872721582.14
BMA income_statement (annual, 2024-12-31) — Occupancy And Equipment: 55653300000.00
BMA cash_flow (annual, 2024-12-31) — Operating Cash Flow: 2633788066000.00
BMA cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -507537281000.00
BMA cash_flow (annual, 2024-12-31) — Operating Gains Losses: -303462160000.00
BMA cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -124397750000.00
BMA income_statement (annual, 2024-12-31) — Operating Revenue: 5949817365000.00
BMA income_statement (quarterly, 2024-12-31) — Operating Revenue: 1086773191000.00
BMA balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 639413408.00
BMA balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 639413408.00
BMA cash_flow (annual, 2024-12-31) — Other Cash Adjustment Outside Changein Cash: -2359606922000.00
BMA cash_flow (quarterly, 2024-12-31) — Other Cash Adjustment Outside Changein Cash: -371111072000.00
BMA balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 4350258266000.00
BMA balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 4350258266000.00
BMA balance_sheet (annual, 2024-12-31) — Other Equity Interest: 1649395543000.00
BMA balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: 1649395543000.00
BMA income_statement (annual, 2024-12-31) — Other Gand A: 326007766000.00
BMA income_statement (quarterly, 2024-12-31) — Other Gand A: 73191798000.00
BMA balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 194002732000.00
BMA balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 194002732000.00
BMA cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1305851829000.00
BMA cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 330400360000.00
BMA income_statement (annual, 2024-12-31) — Other Non Interest Expense: 660160541000.00
BMA income_statement (quarterly, 2024-12-31) — Other Non Interest Expense: 143781490000.00
BMA income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -2359350148000.00
BMA income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -374809251000.00
BMA balance_sheet (annual, 2024-12-31) — Other Payable: 1127999303000.00
BMA balance_sheet (quarterly, 2024-12-31) — Other Payable: 1127999303000.00
BMA balance_sheet (annual, 2024-12-31) — Other Properties: 973463258000.00
BMA balance_sheet (quarterly, 2024-12-31) — Other Properties: 973463258000.00
BMA balance_sheet (annual, 2024-12-31) — Other Receivables: 693165250000.00
BMA balance_sheet (quarterly, 2024-12-31) — Other Receivables: 693165250000.00
BMA balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 577109328000.00
BMA balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 577109328000.00
BMA income_statement (annual, 2024-12-31) — Other Special Charges: 3118510118000.00
BMA income_statement (quarterly, 2024-12-31) — Other Special Charges: 11180382000.00
BMA balance_sheet (annual, 2024-12-31) — Payables: 1344364272000.00
BMA balance_sheet (quarterly, 2024-12-31) — Payables: 1344364272000.00
BMA balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 1379388641000.00
BMA balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 1379388641000.00
BMA balance_sheet (annual, 2024-12-31) — Prepaid Assets: 44561383000.00
BMA balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 44561383000.00
BMA income_statement (annual, 2024-12-31) — Pretax Income: 473594762000.00
BMA income_statement (quarterly, 2024-12-31) — Pretax Income: 168220661000.00
BMA cash_flow (annual, 2024-12-31) — Purchase Of Business: -11216178000.00
BMA cash_flow (annual, 2024-12-31) — Purchase Of PPE: -163799643000.00
BMA cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -38164503000.00
BMA balance_sheet (annual, 2024-12-31) — Receivables: 1361839455000.00
BMA balance_sheet (quarterly, 2024-12-31) — Receivables: 1361839455000.00
BMA income_statement (annual, 2024-12-31) — Reconciled Depreciation: 181722120000.00
BMA income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 44975387000.00
BMA income_statement (annual, 2024-12-31) — Rent And Landing Fees: 1869846000.00
BMA income_statement (quarterly, 2024-12-31) — Rent And Landing Fees: 325258000.00
BMA income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 1869846000.00
BMA income_statement (quarterly, 2024-12-31) — Rent Expense Supplemental: 325258000.00
BMA cash_flow (annual, 2024-12-31) — Repayment Of Debt: -153573471000.00
BMA cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -73644755000.00
BMA balance_sheet (annual, 2024-12-31) — Retained Earnings: -686204399000.00
BMA balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -686204399000.00
BMA income_statement (annual, 2024-12-31) — Salaries And Wages: 949646887000.00
BMA income_statement (quarterly, 2024-12-31) — Salaries And Wages: 219659572000.00
BMA income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 57335522000.00
BMA income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 8041489000.00
BMA income_statement (annual, 2024-12-31) — Selling General And Administration: 1374007598000.00
BMA income_statement (quarterly, 2024-12-31) — Selling General And Administration: 309401784000.00
BMA balance_sheet (annual, 2024-12-31) — Share Issued: 639413408.00
BMA balance_sheet (quarterly, 2024-12-31) — Share Issued: 639413408.00
BMA income_statement (annual, 2024-12-31) — Special Income Charges: -3118510118000.00
BMA income_statement (quarterly, 2024-12-31) — Special Income Charges: -11180382000.00
BMA balance_sheet (annual, 2024-12-31) — Stockholders Equity: 5326518604000.00
BMA balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 5326518604000.00
BMA balance_sheet (annual, 2024-12-31) — Tangible Book Value: 5132515872000.00
BMA balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 5132515872000.00
BMA income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -290290507131.25
BMA income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: -2390433417.86
BMA income_statement (annual, 2024-12-31) — Tax Provision: 44099600000.00
BMA income_statement (quarterly, 2024-12-31) — Tax Provision: 37437861000.00
BMA income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.09
BMA income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.22
BMA cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -423864372000.00
BMA cash_flow (quarterly, 2024-12-31) — Taxes Refund Paid: -23944481000.00
BMA balance_sheet (annual, 2024-12-31) — Total Assets: 19064605229000.00
BMA balance_sheet (quarterly, 2024-12-31) — Total Assets: 19064605229000.00
BMA balance_sheet (annual, 2024-12-31) — Total Capitalization: 5895421225000.00
BMA balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 5895421225000.00
BMA balance_sheet (annual, 2024-12-31) — Total Debt: 587304495000.00
BMA balance_sheet (quarterly, 2024-12-31) — Total Debt: 587304495000.00
BMA balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 5328662213000.00
BMA balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 5328662213000.00
BMA balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 13735943016000.00
BMA balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 13735943016000.00
BMA balance_sheet (annual, 2024-12-31) — Total Tax Payable: 216363353000.00
BMA balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 216363353000.00
BMA income_statement (annual, 2024-12-31) — Total Unusual Items: -3117490037000.00
BMA income_statement (quarterly, 2024-12-31) — Total Unusual Items: -10741006000.00
BMA income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -3117490037000.00
BMA income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -10741006000.00
BMA income_statement (quarterly, 2025-03-31) — +Total Revenue: 1074994960000.00
BMA balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -322807916000.00
BMA balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 12429781000.00
BMA balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 4095524188000.00
BMA income_statement (quarterly, 2025-03-31) — Basic Average Shares: 63941300.00
BMA income_statement (quarterly, 2025-03-31) — Basic EPS: 930.13
BMA cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 4122610876000.00
BMA cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -48133863000.00
BMA balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 16804007000.00
BMA balance_sheet (quarterly, 2025-03-31) — Capital Stock: 639413000.00
BMA balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 2240854310000.00
BMA balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 2297122350000.00
BMA balance_sheet (quarterly, 2025-03-31) — Cash Financial: 327957399000.00